2016
DOI: 10.1016/j.nicl.2016.04.012
|View full text |Cite
|
Sign up to set email alerts
|

Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1

Abstract: BackgroundMyotonic dystrophy type 1 (DM1) represents a multisystemic disorder in which diffuse brain white and gray matter alterations related to clinical and genetic features have been described. We aimed to evaluate in the brain of adult patients with DM1 (i) white and gray matter differences, including cortical-subcortical gray matter volume and cortical thickness and (ii) their correlation with clinical disability, global neuropsychological performance and triplet expansion.MethodsWe included 24 adult gene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

9
66
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 56 publications
(75 citation statements)
references
References 60 publications
(75 reference statements)
9
66
0
Order By: Relevance
“…Subcortical involvement in DM1 has repeatedly been ª 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association reported 26,28,29,[40][41][42] and this is confirmed in our study. Moreover only in the adult/late subgroup was the opposite result found, primarily located in the temporal lobe.…”
Section: Discussionsupporting
confidence: 90%
“…Subcortical involvement in DM1 has repeatedly been ª 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association reported 26,28,29,[40][41][42] and this is confirmed in our study. Moreover only in the adult/late subgroup was the opposite result found, primarily located in the temporal lobe.…”
Section: Discussionsupporting
confidence: 90%
“…In contrast, Parkinson’s is characterized by the loss of dopaminergic neurons in the substantia nigra (Shulman et al, 2011) and Huntington disease for loss of medium spiny neurons in the striatum (Vonsattel et al, 2011). Although CNS features in DM, including executive function deficits, are highly problematic for patients and white matter abnormalities are detected by MRI and pathological examination (Minnerop et al, 2011; Ogata et al, 1998), routine pathological findings are diffuse and previous reports suggest findings are non-specific (Conforti et al, 2016; Wozniak et al, 2013; Wozniak et al, 2014; Wozniak et al, 2011; Zanigni et al, 2016). The discovery that LPAC and QAGR tetrapeptide proteins accumulate in DM2 provides a new opportunity to understand the impact of the DM2 expansion mutation on the brain and to look for pathological findings at sites of RAN protein accumulation.…”
Section: Discussionmentioning
confidence: 99%
“…Consistent evidence has been produced proving that structural and functional changes in DM1 brains account for some specific higher-level dysfunctions. So far, structural magnetic resonance imaging (MRI) studies have mainly focused on the assessment of regional gray matter volumetric and microstructural changes of the white matter tissue (4)(5)(6)(7)(8)(9)(10)(11)(12). Importantly, a strict relationship has been reported not only between structural brain abnormalities and DM1 patients' cognitive profile (e.g., executive functions, reasoning and visuospatial abilities) (7,9) but also with patients' CTG triplet expansion (6,8,13).…”
Section: Introductionmentioning
confidence: 99%